Delivery Order SPE2DB25D2207-SPE2DB25FQQUA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $54,001.92 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $12,260.04. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for completion by May 13, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on November 5, 2025, with a ceiling value of $6,624.83. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $10,329.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used for stroke prevention and blood clot treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $44,263.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $12,612.95. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order valued at $17,793.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.53 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veterans' healthcare...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQQUADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,636.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is a widely-used anticoagulant medication essential for military healthcare systems and veteran medical programs supported by the Defense Logistics Agency's medical supply chain. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical prime vendor agreement running through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare globally. The company's history of competitive awards and its role as a pharmaceutical prime vendor demonstrates its capacity to fulfill critical federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 4/24/25 |